MHIF blog

Traverse Publishes First-in-Human Porcine ECM Study Results

MHIF is proud to have been the leading enroller and clinical site in the first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that was evaluated for safety and feasibility in repairing damage and restoring cardiac function in heart failure patients who previously suffered a heart attack, sponsored by Ventrix, Inc (San Diego, CA).

MHIF Team Publishes New STEMI-SCAD Research

Research Shows Reperfusion with Primary Percutaneous Coronary Intervention is Successful in Most STEMI-SCAD Patients Largest known study compared strategies and outcomes for STEMI-SCAD with STEMI-ATH MINNEAPOLIS / September 10, 2019: Spontaneous coronary artery...

First in World TRILUMINATE Enrollment at MHIF

Minneapolis Heart Institute Foundation®Enrolls Patient in World’s First Pivotal Trial Testing New Approach for Repairing Leaky Tricuspid Heart Valves TRILUMINATE Pivotal trial is the randomized clinical trial to evaluate transcatheter tricuspid valve repair using...

Harris Published in EHJ for Treadmill Workstation in Echo Lab

MHIF Researcher and Minneapolis Heart Institute Cardiologist, Dr. Kevin Harris recently published a paper in the European Heart Journal on the use of a treadmill workstation (TW) in the echocardiography laboratory. In the works since 2014, this first-of-its-kind study...

2019 Intern Cohort Recap

The summer research interns had their final research poster presentations in the newly remodeled space at MHIF on August 8th. Approximately 150 guests joined the interns to see and learn about the great research the interns completed over the summer with their...

Dr. Scott Sharkey on Kare11 for Women’s Heart Research

Click on image above to watch Dr. Sharkey's segment on Kare 11. Dr. Scott Sharkey, MHIF Chief Medical Officer and Cardiologist at Minneapolis Heart Institute® recently had the opportunity to sit down with Kare 11's Rena Sarigianopoulos to discuss women's heart health...

MHIF at CVI 2019

MHIF was well represented at the 2019 Cardiovascular Innovations conference in Denver, CO in July. Dr. Paul Sorajja, Roger L. and Lynn C. Headrick Family Chair for Valve Science Research at MHIF’s Valve Science Center, and Dr. Manos Brilakis, Chair of MHIF's Complex...

Hope, Health & Humor Event Recap – 5 Takeaways

  Did you know that women’s heart health research is 35 years behind that of men? When it comes to heart disease, women are under-studied, under-diagnosed and under-treated. At our fourth annual Hope, Health & Humor event held Aug. 8, 2019, the Minneapolis...

2018 MHI/MHIF Research Dissemination

Research is at the core of our mission. By disseminating our research learnings to medical professionals we are improving the prevention, identification and treatment of heart and vascular disease. In 2018 alone, our team published 200 manuscripts, produced 87 poster...

2019 Heartbeat Gala

Please join us for the 2019 Heartbeat Gala The stories shared will shine a light on the need for, and impact of, women's heart health research. Join gala co-chairs, Dr. Elizabeth Grey and Dr. Retu Saxena as we lift up the impact research has on the lives of patients...